Insider Selling: Grail, Inc. (NASDAQ:GRAL) CFO Sells $426,937.04 in Stock

Grail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin sold 30,452 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the transaction, the chief financial officer now directly owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. This represents a 10.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Grail Stock Up 8.5 %

GRAL opened at $16.38 on Friday. The firm’s 50 day moving average is $13.90. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $23.36.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Guggenheim assumed coverage on Grail in a research report on Thursday, October 17th. They set a “neutral” rating for the company. Wolfe Research assumed coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company.

Grail Company Profile

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.